ARTICLE
Auteur(s) : Carlo Tomasini, Zelda
Seia, Paolo Dapavo, Elisabetta Soro, Chiara Addese, Mario
Pippione
Department of Biomedical Science and Human Oncology, Second
Dermatologic Clinic, University of Turin, Via Cherasco 23, 10126
Turin, Italy
accepté le 19 Juin 2006
Erythema elevatum diutinum (EED) was originally described in 1888
by Hutchinson and in 1889 by Bury [1, 2]. However, the name EED was
first used by Radcliff, Crocker and Williams, who found
similarities between the cases of Hutchinson and Bury and their own
[3]. This disease is considered rather uncommon, but it is probably
less rare than the published cases would suggest, as the diagnosis
is often overlooked.EED is a localized, low-grade form of
leukocytoclastic vasculitis of unknown pathogenesis occurring most
frequently in adults, although any age may be involved [4]. The
clinical presentation is highly characteristic with persistent,
symmetrical, red-purple papules, nodules, and plaques especially
affecting the extensor surfaces of the extremities, the ears, trunk
and buttocks. Atypical presentations with vesiculo-bullous,
hemorrhagic and ulcerative lesions have occasionally been reported
[5, 6]. Arthralgia is sometimes present. The course is exceedingly
chronic with a slow healing, fibrotic phase [7, 8].We describe a
case of EED in a child presenting with vesiculo-bullous lesions and
discuss problems of differential diagnosis that it created.
Case report
A 9-year-old child presented with a 6-month history of red-purple
papules, plaques and vesiculo-bullous lesions distributed over the
ears and extensor surfaces of the upper and lower extremities and
buttocks (figures 1 and 2). Some lesions involuted
spontaneously leaving hyperpigmented atrophic scars. The old
lesions were asymptomatic, but the new ones were associated with
pruritus and a burning sensation. Clinical diagnostic
considerations included mainly dermatitis herpetiformis and
leukocytoclastic vasculitis. Medical history revealed recurrent
episodes of pharyngotonsillitis during the last 12 months.
Laboratory investigations showed an elevated erythrocyte
sedimentation rate (28 mm/h; normal range 0-14 mm/h) and
an elevated antistreptolysin O titre (290 UI/mL; normal range
20-250 UI/mL). Culture of a swab taken from the pharynx was
positive for Streptococcus pyogenes. Circulating antibodies to
gliadin, transglutaminase, and nuclear antigens were negative. Two
skin biopsies were taken: one from a vesiculo-bullous lesion on the
right buttock and one from an indurated plaque on the left leg.
Histopathologic examination of the biopsy from the periphery of a
vesiculo-bullous lesion showed a dense, perivascular superficial
and deep dermal infiltrate composed mostly of neutrophils and
eosinophils. Extensive leukocytoclasia and focal fibrin necrosis of
small vessel walls were also observed. Collections of neutrophils
and nuclear dust were seen in edematous papillae and in
subepidermal spaces ( (figure 3) ). The biopsy of
the long-standing plaque showed a scant infiltrate of neutrophils
with nuclear dust throughout zones of marked dermal fibrosis and
increased vascularity ( (figure 4) ). Direct
immunofluorescence demonstrated IgG and C3 deposits within vessels
in the upper dermis. The child was initially treated with
clarythromicin 500 mg daily for 10 days with slight improvement of
the dermatosis. As EED is an inflammatory disease mainly mediated
by neutrophils, we then treated this patient with
diamino-diphenyl-sulphone (dapsone), a drug that inhibits lysosomal
enzyme activity and interferes with the
myeloperoxidase-H2O2-halide-mediated
cytotoxic system in polymorphonuclear leukocytes [5, 9, 10]. A dose
of 50 mg/day was given for two weeks with a prompt and dramatic
response, and then the drug was tapered to 25 mg daily for 4 weeks.
A maintenance dose of 12.5 mg/day was continued for 6 months with
no recurrence of the dermatosis. A tonsillectomy was also performed
after that period. At a 2 year-follow-up the patient remained
disease-free.
Discussion
EED is a rare skin disease that initially presents as
leucocytoclastic vasculitis and later resolves with fibrosis [7,
8]. This disease can occur at any age, with a peak incidence from
the third to the sixth decade of life. EED is found in both males
and females; the latter are younger than males and usually have
concurrent rheumatologic disorders [6, 11]. Only a few pediatric
cases have been described in the literature [2, 3, 12-16].
Clinically EED poses problems of differential diagnosis with
Sweet’s syndrome, pyoderma gangrenosum, granuloma anulare and,
sometimes, dermatitis herpetiformis [17]. In our patient, the early
age and the clinical presentation with vesiculo-bullous lesions on
the extremities and buttocks strongly suggested During’s disease.
Histopathologically the presence of collections of neutrophils in
dermal papillae and subepidermal spaces in association with nuclear
dust could also evoke this diagnosis, although in dermatitis
herpetiformis the infiltrate is usually confined to the superficial
dermis and vasculitis is absent. Most importantly,
immunopathologically, in dermatitis herpetiformis granular deposits
of IgA are found at the tips of dermal papillae [17].
The cause of EED has not yet been definitively established.
Disorders that have been associated with EED include bacterial
infections, viral infections and rheumatologic diseases [18-25].
Recently, several reports have highlighted haematologic diseases as
the most common associations with EED, especially IgA monoclonal
gammopathy [26].
Pathogenetically, cutaneous lesions of EED are presumed to be
the consequence of an Arthus-type reaction to bacterial and viral
agents. Antibodies would bind bacterial or viral antigens forming
circulating immune complexes which are then deposited in dermal
vessels with activation of the complement cascade, neutrophil
attraction and vessel injury [25, 27]. In our case, the presence of
immunological deposits in the vessel walls is in keeping with this
view.
The occurrence of the dermatosis in childhood is very rare, with
only a few documented cases in the literature [2, 3, 12-16, 27, 28]
(table 1( Table 1 )). By reviewing the
ancient literature on this subject, what would seem to be the first
pediatric case of EED was chronicled in 1889 by Bury who described
a 12-year-old girl suffering from rheumatic fever who developed
purplish plaques on her hands and upper limbs [2]. In 1894
Radcliffe, Crocker and Williams reported on a 6-year-old girl with
a similar condition, who had a history of rheumatism [3]. In 1904
Audry published a further case in a 7-year-old boy in whom bullous
lesions were observed [12]. In 1960, Kalkoff described a 5-year-old
child with EED in whom herpetiform blisters developed on several
occasions [13]. In 1966 Thiers showed a 7-year-old child with EED
who had recurrent streptococcal throat infections and who developed
a bullous eruption [14]. In the series of 13 cases of EED described
by Wilkinson et al. in 1992 [27], one patient was a 5-year-old
female suffering from chronic gingivitis, nasal obstruction and
bilateral conjunctivitis who developed an exceedingly chronic,
poorly responsive eruption with blister formation. In 1993,
Miyagawa et al. reported on a 3-year-old girl suffering from
hyperimmunoglobulinemia D syndrome with recurrent erythematous
plaques and vesiculo-bullous lesions of 2 years duration [15].
Interestingly, at 4 months of age the child had staphyloccocal
scalded skin syndrome and successively recurrent febrile attacks
associated with upper respiratory tract infections.
It is worth noting that in a significant proportion of these
cases, the eruption had a vesiculo-bullous presentation.
Furthermore, the relationship between streptococcal infection and
some pediatric cases of EED would not seem coincidental. The marked
reaction to intradermally injected antigens of streptococci with
induction of leukocytoclastic vasculits in some patients with EED
[19, 25] also supports the view that in EED an Arthus type reaction
induced by bacterial antigens may be operative.
What remains unclear is the relationship, if any, between
pediatric cases of EED and dermatitis herpetiformis and/or celiac
disease, as in a case described by Degos in 1952 [29] and in
another patient reported by Rodriguez-Serna [28].
In the presence of cutaneous conditions with no clear-cut
clinicopathologic features, as also in the case chronicled by
Tasanen et al. [30], direct immunofluorescence studies of biopsies
from uninvolved skin and duodenal/jejunal biopsies should be
regarded definitely diagnostic for the conundrum.
In sum, we described a case of EED in a child with clinical and
histopathologic features mimicking dermatitis herpetiformis.
Clinicians should be aware of atypical clinico-pathologic
presentations of EED in children in order to avoid misdiagnoses
Table 1 Erythema elevatum diutinum in childhood
|
Case
|
Age
|
Sex
|
History
|
Lesions
|
Site
|
|
Bury [2] 1889
|
12
|
F
|
Rheumatic fever 3 years previously
|
Nodules and purplish plaques
|
Hands, fingers and one forearm
|
|
Radcliffe Crocker [3] 1894
|
6
|
F
|
Family history of rheumatism
|
Nodules and purplish plaques
|
Hands, fingers
|
|
Audry [12] 1904
|
9
|
M
|
Not reported
|
Bullous eruption
|
Limbs and trunk
|
|
Kalkoff [13] 1960
|
5
|
F
|
Not reported
|
Plaques and, 6 months later, herpetiforms blisters
|
Buttocks and extensor surfaces of the arms and legs and, later, on
face, knees and axillae
|
|
Thiers [14] 1966
|
7
|
M
|
Recurrent streptococcal throat infections
|
Bullous eruption
|
Skin and mucous membranes
|
|
Wilkinson [27] 1992
|
5
|
F
|
Chronic gingivitis, nasal obstruction, bilateral conjunctivitis
|
Papules and plaques with blisters
|
Buttocks, elbows, knees and dorsa of the feet
|
|
Miyagawa [15] 1993
|
3
|
F
|
Chronic upper respiratory tract infection, hypergammaglobulinemia
D
|
Papules, plaques, vesicles
|
Face, ears, buttocks, extensor surfaces of the limbs, conjunctive,
oral mucosa and tongue
|
|
Rodriguez-Serna [28] 1993
|
11
|
F
|
Diabetes mellitus, celiac disease, kidney disease
|
Plaques
|
Limbs
|
|
Hernandez-Cano [16] 1998
|
10
|
M
|
Cyclosporin treatment after liver transplantation
|
Papules
|
Hands
|
|
Present case
|
9
|
M
|
Recurrent episodes of pharyngotonsillitis
|
Purplish papules, plaques and vesiculo-bullous lesions
|
Ears and extensor surfaces of the arms, legs and buttocks
|
References
1 Hutchinson J. On two remarkable cases of symmetrical purple
congestion of the skin in patches, with induration. Br J Dermatol
1888; 1: 10-5.
2 Bury JS. A case of erythema with remarkable nodular
thickening and induration of skin associated with intermittent
albuminuria. Illus Med News 1889; 3: 145-7.
3 Radcliff H, Crocker H, Williams C. Erythema
elevatum diutinum. Br J Dermatol 1894; 6: 33-8.
4 Gibson LE, el-Azahry RA. Erythema elevatum diutinum.
Clin Dermatol 2000; 18: 259-69.
5 Dorothy I. Erythema elevatum diutinum-vesicular lesions
and sulphone response. Br J Derm 1968; 80: 178-83.
6 Gerbig AW, Zala L, Hunziker T. Erythema
elevatum diutinum. A rare dermatosis with a broad spectrum of
illnesses. Hautartz 1997; 48: 113-7.
7 Le Boit PE, Yen TSB, Wintroub B. The evolution
of lesions in erythema elevatum diutinum. Am J Dermatopathol 1986;
8: 392-402.
8 Porneuf M, Duterque M, Sotto A, Jourdan J.
Unusual erythema elevatum diutinum with fibrohistiocytic
proliferation. Br J Dermatol 1996; 134: 1131-4.
9 Grabbe J, Haas N, Moller A, Henz BM.
Erythema elevatum diutinum-evidence for disease-dependent leucocyte
alterations and response to dapsone. Br J Dermatol 2000; 143:
415-20.
10 Kazmierowski JA, Ross JE, Peizner DS,
Wuepper KD. Dermatitis herpetiformis: effects of sulfones and
sulfonamides on neutrophil myeloperoxidase-mediated iodinations and
cytotoxicity. J Clin Immunol 1984; 4: 55-64.
11 Sangueza OP, Pilcher B, Sangueza JM. Erythema
elevatum diutinum: a clinicopathological study of eight cases. Am J
Dermatopathol 1997; 19: 214-22.
12 Audry C. Des érythémato-sclérose et, particulièrement,
de l’érythémato-sclérose pemphigoide. Annl Derm Syph 1904; 5:
1.
13 Kalkoff KW. Zur Behandlung des EED mit
3-sulphonilamido-6-methoxy-pyridazin. Dermatol Wochenschr 1960;
142: 788-91.
14 Thiers H, Revol L, Romagny G, Moulin G,
Cuffia C, Silie M. Erythema elevatum diutinum associé à
d’autres manifestations d’angio-nécrose cutanée allergique. Lyon
Med 1966; 216: 284-6.
15 Miyagawa S, Kitamura W, Morita K,
Saishin M, Shirai T. Association of
hyperimmunoglobulinaemia D syndrome with erythema elevatum
diutinum. Br J Dermatol 1993; 128: 572-4.
16 Hernandez-Cano N, De Lucas R, Lazaro TE,
Mayor M, Buron I, Casado M. Erythema elevatum
diutinum after liver transplantation: disappearance of the lesions
associated with a reduction in cyclosporin dosage. Pediatr Dermatol
1998; 15: 411-2.
17 Woollons A, Darley CR, Bhogal BS,
Black MM, Atherton DJ. Childhood dermatitis
herpetiformis: an unusual presentation. Clin Exp Dermatol 1999; 24:
238-45.
18 Weidman FD, Besancon JH. Erythema elevatum
diutinum: role of streptococci, and relationship to other rheumatic
dermatoses. Arch Dermatol 1929; 20: 593-620.
19 Cream JJ, Levene GM, Calleman CD. Erythema
elevatum diutinum: an unusual reaction to streptococcal antigen and
response to dapsone. Br J Dermatol 1971; 84: 393-6.
20 Drago F, Semino M, Rampini P, Lugani C,
Rebora A. Erythema elevatum diutinum in a patient with human
herpesvirus 6 infection. Acta Derm Venereol 1999; 79: 91-2.
21 Muratori S, Carrera C, Gorani A,
Alessi E. Erythema elevatum diutinum and HIV infection: a
report of five cases. Br J Dermatol 1999; 141: 335-8.
22 Sanz-Trelles A, Ayala-Carbonero A,
Ojeda-Martos A. Erythema elevatum diutinum in a HIV+
hemophilic patient. Am J Dermatopathol 1999; 21: 587-9.
23 Martin JIF, Dronda F, Chavest F. Erythema
elevatum diutinum, a clinical entity to be considered in patients
infected with HIV-1. Clin Exp Dermatol 2001; 26: 725-32.
24 Dronda F, Gonzalez-Lopez A, Lecona M,
Barros C. Erythema elevatum diutinum in human immunodeficiency
virus-infected patients- report of a case and review of the
literature. Clin Exp Dermatol 1996; 21: 222-5.
25 Wolff HH, Scherer R, Maciejewsky W,
Braun-Falco O. Erythema elevatum diutinum: immunoelectron
microscopical study of leukocytoclasic vasculitis within the
intracutaneous test reaction induced by streptococcal antigen. Arch
Dermatol Res 1978; 261: 17-26.
26 Chow RKP, Barret BW, Coupe RL, Dodd WA,
Ongley RC. Erythema elevatum diutinum associated with
paraproteinemia successfully controlled with intermittent plasma
exchange. Arch Dermatol 1996; 132: 1360-4.
27 Wilkinson SM, English JS, Smith NP,
Wilson-Jones E, Winkelmann RK. Erythema elevatum
diutinum: a clinicopathological study. Clin Exp Dermatol 1992; 17:
87-93.
28 Rodriguez-Serna M, Fortea JM, Perez A,
Febrer I, Ribes C, Aliaga Z. Erythema elevatum
diutinum associated with celiac disease: response to a gluten-free
diet. Pediatr Dermatol 1993; 10: 125-8.
29 Degos R, Perin L, Lortat-Jacob E,
Hewitt J. “Erythema elevatum diutinum” avec infiltrations
lipoidiques au cours d’une affection bulleuse type During. Bull Soc
Fr Dermatol Syphiligr 1952; 59: 226-30.
30 Tasanen K, Raudasoja R, Kallioinen M,
Ranki A. Erythema elevatum diutinum in association with
coeliac disease. Br J Dermatol 1997; 136: 624-32.
|